Conclusions Systematic identification of new-onset arrhythmias following TAVI may have considerable impact on subsequent therapeutic management and long-term prognosis in this patient population
Objective To evaluate the prevalence and clinical impact of new-onset arrhythmias in patients following transcatheter aortic valve implantation ( TAVI ) .
In-office insertion of a miniaturized insertable cardiac monitor: Results from the Reveal LINQ In-Office 2 randomized study.
BACKGROUND Recent miniaturization of an insertable cardiac monitor ( ICM ) may make it possible to move device insertion from a hospital to office setting . However , the safety of this strategy is unknown . OBJECTIVES The primary objective was to compare the safety of inserting the Reveal LINQ ICM in an office vs a hospital environment . Ancillary objectives included summarizing device- and procedure-related adverse events and responses to a physician question naire . METHODS Five hundred twenty-one patients indicated for an ICM were r and omized ( 1:1 ratio ) to undergo ICM insertion in a hospital or office environment at 26 centers in the United States in the Reveal LINQ In-Office 2 study ( Clinical Trials.gov identifier NCT02395536 ) . Patients were followed for 90 days . RESULTS ICM insertion was successful in all 482 attempted patients ( office : 251 ; hospital : 231 ) . The untoward event rate ( composite of unsuccessful insertion and ICM- or insertion-related complications ) was 0.8 % ( 2 of 244 ) in the office and 0.9 % ( 2 of 227 ) in the hospital ( 95 % confidence interval , -3.0 % to 2.9 % ; 5 % noninferiority : P < .001 ) . In addition , adverse events occurred during 2.5 % ( 6 of 244 ) of office and 4.4 % ( 10 of 227 ) of hospital insertions ( 95 % confidence interval [ office minus inhospital rates ] , -5.8 % to 1.9 % ; 5 % noninferiority : P < .001 ) . Physicians indicated that for procedures performed in an office vs a hospital , there were fewer delays > 15 minutes ( 16 % vs 35 % ; P < .001 ) and patient response was more often " very positive . " Physicians considered the office location " very convenient " more frequently than the hospital location ( 85 % vs 27 % ; P < .001 ) . CONCLUSION The safety profile for the insertion of the Reveal LINQ ICM is excellent irrespective of insertion environment . These results may exp and site of service options for LINQ insertion
Conclusions Systematic identification of new-onset arrhythmias following TAVI may have considerable impact on subsequent therapeutic management and long-term prognosis in this patient population
Objective To evaluate the prevalence and clinical impact of new-onset arrhythmias in patients following transcatheter aortic valve implantation ( TAVI ) .